Claims for Patent: 12,357,602

Summary for Patent: 12,357,602

Title:	Compositions comprising encapsulated tretinoin
Abstract:	The present application is directed to compositions comprising microcapsules comprising encapsulated tretinoin, wherein the microcapsule size is less than 50 μm; and to methods of use thereof.
Inventor(s):	Ofer Toledano, Karine Neimann, Maya Erlich, Dorit Marco
Assignee:	Mayne Pharma LLC
Application Number:	US16/033,260
Patent Claims:	1. A composition comprising: microcapsules comprising tretinoin, wherein: said microcapsules comprise a core containing tretinoin dispersed in an oil and a phase changing material and a metal oxide shell; and wherein said tretinoin is in solid form and said microcapsules have a D90 between 30 μm to 50 μm; and wherein said tretinoin is in the range of 0.01%-0.1% by weight of the composition; and microcapsules comprising solid benzoyl peroxide with a metal oxide shell; wherein said benzoyl peroxide is in an amount of 3% by weight of the composition; wherein degradation of said tretinoin is less than 2.5% after two weeks storage at 40° C. and 75% relative humidity. 2. The composition according to claim 1, wherein said tretinoin is in the amount of between 0.05% and 0.1% weight of the composition. 3. The composition according to claim 2, wherein said tretinoin is in the amount of 0.075% weight of the composition. 4. The composition according to claim 1, wherein the composition comprises a carrier, wherein the carrier is in the form of an ointment, a cream, a lotion, an oil, a solution, an emulsion, a gel, a paste, a milk, an aerosol, a powder, or a foam. 5. The composition according to claim 1, wherein the concentration of all-trans 5,6-epoxy retinoic acid after two weeks storage at 40° C. and 75% relative humidity is less than 1% by weight of the initial tretinoin amount prior to storage. 6. The composition according to claim 1, wherein the degradation of said tretinoin is less than 2%. 7. The composition according to claim 1, wherein the degradation of said tretinoin is not more than 5% by weight of the initial tretinoin amount, after 18 or 24 months storage at 2° C.-8° C. 8. The composition according to claim 1, wherein the degradation of said tretinoin is not more than 5% by weight of the initial tretinoin amount, after 3 months storage at 25° C. and 60% RH. 9. The composition according to claim 1, wherein the composition comprises a carrier, wherein the carrier is in the form of an ointment, a cream, a lotion, an oil, an emulsion, or a gel. 10. The composition according to claim 9, wherein the amount of said tretinoin is 0.1% weight of the composition and the amount of said benzoyl peroxide is 3% weight of the composition. 11. The composition of claim 1, wherein said composition has a tretinoin dissolution rate of less than 60% weight/h as measured in a medium of 30%:70% V/V mixture of water and isopropyl alcohol at ambient temperature. 12. The composition according to claim 11, wherein said composition has a tretinoin dissolution rate of less than 40% weight/h. 13. A method for treating a skin disease, disorder or condition selected from acne, infection, inflammation, pruritus, psoriasis, seborrhea, contact dermatitis, rosacea, melasma, photoaging, photodamage, fine wrinkles, and a combination thereof in a subject in need thereof, said method comprising topically administering to said subject a composition according to claim 1. 14. A method for treating a skin disease, disorder or condition selected from acne, infection, inflammation, pruritus, psoriasis, seborrhea, contact dermatitis, rosacea, melasma, photoaging, photodamage, fine wrinkles, and a combination thereof in a subject in need thereof, said method comprising topically administering to said subject a composition according to claim 11.